- Article
Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7
- Abdelhamid Nacereddine,
- Andre Bollacke,
- Eszter Róka,
- Christelle Marminon,
- Zouhair Bouaziz,
- Ferenc Fenyvesi,
- Ildikó Katalin Bácskay,
- Joachim Jose,
- Florent Perret and
- Marc Le Borgne
Since the approval of imatinib in 2001, kinase inhibitors have revolutionized cancer therapies. Inside this family of phosphotransferases, casein kinase 2 (CK2) is of great interest and numerous scaffolds have been investigated to design CK2 inhibito...

